Engur-Ozturk, S. Et Al. 2024. Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'. APMIS , vol.132, no.8 , 594-607.

Engur-Ozturk, S., KAYA TİLKİ, E., CANTÜRK, Z., & DİKMEN, M., (2024). Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'. APMIS , vol.132, no.8, 594-607.

Engur-Ozturk, Selin Et Al. "Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'," APMIS , vol.132, no.8, 594-607, 2024

Engur-Ozturk, Selin Et Al. "Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'." APMIS , vol.132, no.8, pp.594-607, 2024

Engur-Ozturk, S. Et Al. (2024) . "Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'." APMIS , vol.132, no.8, pp.594-607.

@article{article, author={Selin Engur-Ozturk Et Al. }, title={Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'}, journal={APMIS}, year=2024, pages={594-607} }